Pharma, Uncertain Of What To Do With Its Cash, Turns To Share Buybacks
Executive Summary
Pfizer Inc.'s announcement on Feb. 1 that it plans an enormous, near-term share repurchasing program caught investors' attention and highlighted a persistent, if sometimes muted, ongoing debate in the industry about the best use of its cash.